Within the past year, Dr Daniel Javitt has served as a consultant to Sepracor, AstraZeneca, Pfizer, Cypress Bioscience, Merck, Sunovion, Eli Lilly, and BMS, and has received research support from Pfizer, Roche, and Jazz Pharmaceuticals
This guide explains step-by-step how to prepare, inject, store, and dispose of your GLP-1 agonist device, including products such as Ozempic, Trulicity, Victoza, Saxenda, and Wegovy
S.CastellanoD.GalskyM
Senescent cells can play a role in cancer prevention
Clinical efficacy studies of various unimolecular dual and triple agonists targeting the GLP- 1 receptor, GIP receptor, and glucagon receptor have shown promising results when used alone or in conjunction with approved hypoglycemic medications
The lack of controlled human clinical trials means the full safety profile remains unknown